TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 40 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $12,047,000 | +8.0% | 12,157,000 | +7.0% | 0.00% | 0.0% |
Q3 2020 | $11,156,000 | -13.9% | 11,357,000 | -14.3% | 0.00% | 0.0% |
Q2 2020 | $12,962,000 | +4.8% | 13,257,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $12,365,000 | -17.6% | 13,257,000 | -16.0% | 0.00% | 0.0% |
Q4 2019 | $15,000,000 | +6.2% | 15,782,000 | +1.5% | 0.00% | 0.0% |
Q3 2019 | $14,125,000 | -1.7% | 15,542,000 | -1.0% | 0.00% | 0.0% |
Q2 2019 | $14,374,000 | +16.5% | 15,692,000 | +18.1% | 0.00% | 0.0% |
Q1 2019 | $12,337,000 | -4.3% | 13,292,000 | -7.3% | 0.00% | 0.0% |
Q4 2018 | $12,898,000 | -3.0% | 14,342,000 | +1.2% | 0.00% | 0.0% |
Q3 2018 | $13,295,000 | +1.1% | 14,172,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $13,144,000 | +8.8% | 14,172,000 | +3.5% | 0.00% | 0.0% |
Q1 2018 | $12,076,000 | +2.9% | 13,697,000 | +3.0% | 0.00% | 0.0% |
Q4 2017 | $11,734,000 | -2.1% | 13,297,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $11,987,000 | -35.4% | 13,297,000 | -23.1% | 0.00% | -50.0% |
Q2 2017 | $18,569,000 | +11.2% | 17,297,000 | +10.2% | 0.00% | +100.0% |
Q1 2017 | $16,705,000 | +5.3% | 15,697,000 | +8.7% | 0.00% | 0.0% |
Q4 2016 | $15,871,000 | -12.3% | 14,447,000 | +2.6% | 0.00% | -50.0% |
Q2 2014 | $18,087,000 | +16.1% | 14,077,000 | +16.6% | 0.00% | 0.0% |
Q1 2014 | $15,584,000 | +3.5% | 12,077,000 | -15.7% | 0.00% | +100.0% |
Q4 2013 | $15,056,000 | +62.1% | 14,327,000 | +60.5% | 0.00% | 0.0% |
Q3 2013 | $9,288,000 | – | 8,927,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|